The European Investment Bank (EIB) has issued its first Sustainability Awareness Bond worth €500m to support...
Up To Date
Latest News
Around 300 international AMR experts met at ESCMID-ASM drug development conference in Lisbon to discuss the...
Oxford-based Adaptimmune Therapeutics plc has raised US$100m in a registered direct offering of American...
The NHS England announces it will reimburse Novartis’ CAR-T cell therapy Kymriah as treatment for children...
Exosome drug delivery specialist Evox Therapeutics Ltd has closed a €37.1m (£35.5m) Series B financing round...
The EU approved Sanofi’s Cablivi (caplacizumab) as the first antibody therapeutic to treat acquired thrombotic...
Share
